Cargando…
Molecular and Cellular Alterations in Down Syndrome: Toward the Identification of Targets for Therapeutics
Down syndrome is a complex disease that has challenged molecular and cellular research for more than 50 years. Understanding the molecular bases of morphological, cellular, and functional alterations resulting from the presence of an additional complete chromosome 21 would aid in targeting specific...
Autor principal: | Créau, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403492/ https://www.ncbi.nlm.nih.gov/pubmed/22848846 http://dx.doi.org/10.1155/2012/171639 |
Ejemplares similares
-
Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
por: Izzo, Antonella, et al.
Publicado: (2018) -
Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways
por: Ripoll, Clémentine, et al.
Publicado: (2012) -
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
por: Souchet, Benoit, et al.
Publicado: (2015) -
Developmental Defects in Trisomy 21 and Mouse Models
por: Delabar, Jean Maurice, et al.
Publicado: (2006) -
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases
por: Peroni, Edoardo, et al.
Publicado: (2023)